Manamtam, Mizpha Bianca T.

HRN: 26-98-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
CEFUROXIME 1.5GM (VIAL)
05/02/2025
05/03/2025
IV
1.5 GMS
ON CALL TO OR THEN Q 8HRS
NKA
Waiting Final Action 
05/03/2025
CEFUROXIME 500MG (TAB)
05/03/2025
05/09/2025
PO
500mg
Bid
Pelvic Lap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: